dc.creatorPERES-BUZALAF, C.
dc.creatorPAULA, L. de
dc.creatorFRANTZ, F. G.
dc.creatorSOARES, E. M.
dc.creatorMEDEIROS, A. I.
dc.creatorPETERS-GOLDEN, M.
dc.creatorSILVA, C. L.
dc.creatorFACCIOLI, L. H.
dc.date.accessioned2012-10-19T03:43:56Z
dc.date.accessioned2018-07-04T14:59:06Z
dc.date.available2012-10-19T03:43:56Z
dc.date.available2018-07-04T14:59:06Z
dc.date.created2012-10-19T03:43:56Z
dc.date.issued2011
dc.identifierPROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, v.85, n.2, p.75-81, 2011
dc.identifier0952-3278
dc.identifierhttp://producao.usp.br/handle/BDPI/20379
dc.identifier10.1016/j.plefa.2011.04.024
dc.identifierhttp://dx.doi.org/10.1016/j.plefa.2011.04.024
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1617162
dc.description.abstractProstaglandins (PGs) and leukotrienes (LTs) are produced in Mycobacterium tuberculosis (Mtb)-infected lungs and have immune suppressive and protective effects, respectively. Considering that both of these mediators are produced during mycobacterial infection, we investigated the specific and relative biological importance of each in regulating host response in experimental tuberculosis. Administration of celecoxib, which was found to reduce lung levels of PGE(2) and increase LTB(4), enhanced the 60-day survival of Mtb-infected mice in 14%. However administration of MK-886, which reduced levels of LTB(4) but did not enhance PGE(2), reduced 60-day survival from 86% to 43% in Mtb-infected mice, and increased lung bacterial burden. MK-886 plus celecoxib reduced survival to a lesser extent than MK-886 alone. MK-886- and MK-886 plus celecoxib-treated animals exhibited reduced levels of the protective interleukin-12 and gamma-interferon. Our findings indicate that in this model, the protective effect of LTs dominates over the suppressive effect of PGs. (C) 2011 Elsevier Ltd. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCI LTD
dc.relationProstaglandins Leukotrienes and Essential Fatty Acids
dc.rightsCopyright ELSEVIER SCI LTD
dc.rightsrestrictedAccess
dc.subjectMycobacterium tuberculosis
dc.subjectProstaglandins
dc.subjectLeukotrienes
dc.subjectCytokines
dc.subjectImmunomodulation
dc.titleControl of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución